Cochlin, a Secreted von Willebrand Factor Type A Domain-Containing Factor, Is Regulated by Leukemia Inhibitory Factor in the Uterus at the Time of Embryo Implantation

Endocrinology

Volumn 145, Issue 3, 2004, Pages 1410-1418

  Rodriguez, Clara I ^a   Cheng, Jr Gang ^a   Liu, Linda ^a   Stewart, Colin L ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GALACTOSIDASE; COCHLIN; LEUKEMIA INHIBITORY FACTOR; MESSENGER RNA; UNCLASSIFIED DRUG; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; EPITHELIUM; FEMALE; GENE CONTROL; GENE DELETION; INNER EAR; MOUSE; NIDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN SECRETION; REGULATORY MECHANISM; REPRODUCTION; SPLEEN; SUBTRACTIVE HYBRIDIZATION; UPREGULATION; UTERUS; WILD TYPE;

ANIMALS; EMBRYO IMPLANTATION; FEMALE; GENE EXPRESSION REGULATION; GENES, REPORTER; INTEGRASES; INTERLEUKIN-6; LAC OPERON; LEUKEMIA INHIBITORY FACTOR; MICE; MICE, INBRED C3H; MICE, INBRED C57BL; MICE, MUTANT STRAINS; PREGNANCY; PROTEIN STRUCTURE, TERTIARY; PROTEINS; RNA, MESSENGER; UP-REGULATION; VIRAL PROTEINS; VON WILLEBRAND FACTOR;

EID: 1442348118     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2003-1361     Document Type: Article

References (49)

1. Cross JC, Werb Z, Fisher SJ 1994 Implantation and the placenta: key pieces of the development puzzle. Science 266:1508-1518
2. Finn CA, Martin L 1974 The control of implantation. J Reprod Fertil 39:195-206
3. Salamonsen LA, Nie G, Dimitriadis E, Robb L, Findlay JK 2001 Genes involved in implantation. Reprod Fertil Dev 13:41-49
4. Spencer TE, Bazer FW 2002 Biology of progesterone action during pregnancy recognition and maintenance of pregnancy. Front Biosci 7:d1879-d1898
5. Fazleabas AT, Strakova Z 2002 Endometrial function: cell specific changes in the uterine environment. Mol Cell Endocrinol 186:143-147
6. Cheng JG, Rodriguez CI, Stewart CL 2002 Control of uterine receptivity and embryo implantation by steroid hormone regulation of LIF production and LIF receptor activity: towards a molecular understanding of "the window of implantation". Rev Endocr Metab Disord 3:119-126
7. Psychoyos A 1973 Endocrine control of egg implantation. Handbook of physiology. In Greep RO, Astwood EB, eds. Baltimore: Williams & Wilkins; 187-215
8. Stewart CL, Kaspar P, Brunet LJ, Bhatt H, Gadi I, Kontgen F, Abbondanzo SJ 1992 Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor. Nature 359:76-79
9. Chen JR, Cheng JG, Shatzer T, Sewell L, Hernandez L, Stewart CL 2000 Leukemia inhibitory factor can substitute for nidatory estrogen and is essential to inducing a receptive uterus for implantation but is not essential for subsequent embryogenesis. Endocrinology 141:4365-4372
10. Bhatt H, Brunet LJ, Stewart CL 1991 Uterine expression of leukemia inhibitory factor coincides with the onset of blastocyst implantation. Proc Natl Acad Sci USA 88:11408-11412
11. Shen MM, Leder P 1992 Leukemia inhibitory factor is expressed by the preimplantation uterus and selectively blocks primitive ectoderm formation in vitro. Proc Natl Acad Sci USA 89:8240-8244
12. Cheng JG, Chen JR, Hernandez L, Alvord WG, Stewart CL 2001 Dual control of LIF expression and LIF receptor function regulate Stat3 activation at the onset of uterine receptivity and embryo implantation. Proc Natl Acad Sci USA 98:8680-8685
13. Branham WS, Lyn-Cook BD, Andrews A, McDaniel M, Sheehan DM 1991 Growth of neonatal rat uterine luminal epithelium on extracellular matrix. In Vitro Cell Dev Biol Anim 27A:442-446
14. David S, Nadia R 1993 Guide to techniques in mouse development. Methods Enzymol 225:384-404
15. Yu D, Ellis HM, Lee EC, Jenkins NA, Copeland NG, Court DL 2000 An efficient recombination system for chromosome engineering in Escherichia coli. Proc Natl Acad Sci USA 97:5978-5983
16. Copeland NG, Jenkins NA, Court DL 2001 Recombineering: a powerful new tool for mouse functional genomics. Nat Rev Genet 2:769-779
17. Stewart CL 1993 Production of chimeras between embryonic stem cells and embryos. Methods Enzymol 225:823-855
18. Lewandoski M, Meyers EN, Martin GR 1997 Analysis of Fgf8 gene function in vertebrate development. Cold Spring Harb Symp Quant Biol 62:159-168
19. Diatchenko L, Lau YF, Campbell AP, Chenchik A, Moqadam F, Huang B, Lukyanov S, Lukyanov K, Gurskaya N, Sverdlov ED, Siebert PD 1996 Suppression subtractive hybridization: a method for generating differentially regulated or tissue-specific cDNA probes and libraries. Proc Natl Acad Sci USA 93:6025-6030
20. Robertson NG, Khetarpal U, Gutierrez-Espeleta GA, Bieber FR, Morton CC 1994 Isolation of novel and known genes from a human fetal cochlear cDNA library using subtractive hybridization and differential screening. Genomics 23:42-50
21. Robertson NG, Skvorak AB, Yin Y, Weremowicz S, Johnson KR, Kovatch KA, Battey JF, Bieber FR, Morton CC 1997 Mapping and characterization of a novel cochlear gene in human and in mouse: a positional candidate gene for a deafness disorder, DFNA9. Genomics 46:345-354
22. Robertson NG, Resendes BL, Lin JS, Lee C, Aster JC, Adams JC, Morton CC 2001 Inner ear localization of mRNA and protein products of COCH, mutated in the sensorineural deafness and vestibular disorder, DFNA9. Hum Mol Genet 10:2493-2500
23. Ikezono T, Omori A, Ichinose S, Pawankar R, Watanabe A, Yagi T 2001 Identification of the protein product of the Coch gene (hereditary deafness gene) as the major component of bovine inner ear protein. Biochim Biophys Acta 1535:258-265
24. Enders AC, Schlafke S 1969 Cytological aspects of trophoblast-uterine interaction in early implantation. Am J Anat 125:1-29
25. Wilcox AJ, Baird DD, Weinberg CR 1999 Time of implantation of the conceptus and loss of pregnancy. N Engl J Med 340:1796-1799
26. Yoshinaga K 1989 Receptor concept in implantation research. Prog Clin Biol Res 294:379-387
27. Robertson NG, Lu L, Heller S, Merchant SN, Eavey RD, McKenna M, Nadol Jr JB, Miyamoto RT, Linthicum Jr FH, Lubianca Neto JF, Hudspeth AJ, Seidman CE, Morton CC, Seidman JG 1998 Mutations in a novel cochlear gene cause DFNA9, a human nonsyndromic deafness with vestibular dysfunction. Nat Genet 20:299-303
28. Manolis EN, Yandavi N, Nadol Jr JB, Eavey RD, McKenna M, Rosenbaum S, Khetarpal U, Halpin C, Merchant SN, Duyk GM, MacRae C, Seidman CE, Seidman JG 1996 A gene for non-syndromic autosomal dominant progressive postlingual sensorineural hearing loss maps to chromosome 14q12-13. Hum Mol Genet 5:1047-1050
29. Fransen E, Verstreken M, Verhagen WI, Wuyts FL, Huygen PL, D'Haese P, Robertson NG, Morton CC, McGuirt WT, Smith RJ, Declau F, Van de Heyning PH, Van Camp G 1999 High prevalence of symptoms of Ménière's disease in three families with a mutation in the COCH gene. Hum Mol Genet 8:1425-1429
30. Fransen E, Verstreken M, Bom SJ, Lemaire F, Kemperman MH, De Kok YJ, Wuyts FL, Verhagen WI, Huygen PL, McGuirt WT, Smith RJ, Van Maldergem LV, Declau F, Cremers CW, Van De Heyning PH, Cremers FP, Van Camp G 2001 A common ancestor for COCH related cochleovestibular (DFNA9) patients in Belgium and The Netherlands bearing the P51S mutation. J Med Genet 38:61-65
31. de Kok YJ, Bom SJ, Brunt TM, Kemperman MH, van Beusekom E, van der Velde-Visser SD, Robertson NG, Morton CC, Huygen PL, Verhagen WI, Brunner HG, Cremers CW, Cremers FP 1999 A Pro51Ser mutation in the COCH gene is associated with late onset autosomal dominant progressive sensorineural hearing loss with vestibular defects. Hum Mol Genet 8:361-366
32. Kamarinos M, McGill J, Lynch M, Dahl H 2001 Identification of a novel COCH mutation, I109N, highlights the similar clinical features observed in DFNA9 families. Hum Mutat 17:351
33. Eavey RD, Manolis EN, Lubianca J, Merchant S, Seidman JG, Seidman C 2000 Mutations in COCH (formerly Coch5b2) cause DFNA9. Adv Otorhinolaryngol 56:101-102
34. Verhagen WI, Bom SJ, Fransen E, Van Camp G, Huygen PL, Theunissen EJ, Cremers CW 2001 Hereditary cochleovestibular dysfunction due to a COCH gene mutation (DFNA9): a follow-up study of a family. Clin Otolaryngol 26:477-483
35. Kemperman MH, Bom SJ, Lemaire FX, Verhagen WI, Huygen PL, Cremers CW 2002 DFNA9/COCH and its phenotype. Adv Otorhinolaryngol 61:66-72
36. Bom SJ, Kemperman MH, Huygen PL, Luijendijk MW, Cremers CW 2003 Cross-sectional analysis of hearing threshold in relation to age in a large family with cochleovestibular impairment thoroughly genotyped for DFNA9/ COCH. Ann Otol Rhinol Laryngol 112:280-286
37. Trexler M, Banyai L, Patthy L 2000 The LCCL module. Eur J Biochem 267: 5751-5757
38. Liepinsh E, Trexler M, Kaikkonen A, Weigelt J, Banyai L, Patthy L, Otting G 2001 NMR structure of the LCCL domain and implications for DFNA9 deafness disorder. EMBO J 20:5347-5353
39. Tuckwell D 1999 Evolution of von Willebrand factor A (VWA) domains. Biochem Soc Trans 27:835-840
40. Colombatti A, Bonaldo P 1991 The superfamily of proteins with von Willebrand factor type A-like domains: one theme common to components of extracellular matrix, hemostasis, cellular adhesion, and defense mechanisms. Blood 77:2305-2315
41. Colombatti A, Bonaldo P, Doliana R 1993 Type A modules: interacting domains found in several non-fibrillar collagens and in other extracellular matrix proteins. Matrix 13:297-306
42. Whittaker CA, Hynes RO 2002 Distribution and evolution of von Willebrand/ integrin A domains: widely dispersed domains with roles in cell adhesion and elsewhere. Mol Biol Cell 13:3369-3387
43. Woessner Jr JF 1991 Matrix metalloproteinases and their inhibitors in connective tissue remodeling. Faseb J 5:2145-2154
44. Weitlauf HM 1994 Biology of Implantation. In: Knobil E, Neill JD, eds. The physiology of reproduction. 2nd ed. New York: Raven Press Ltd; 391-440
45. Vu TH, Werb Z 2000 Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 14:2123-2133
46. Illera MJ, Juan L, Stewart CL, Cullinan E, Ruman J, Lessey BA 2000 Effect of peritoneal fluid from women with endometriosis on implantation in the mouse model. Fertil Steril 74:41-48
47. Illera MJ, Cullinan E, Gui Y, Yuan L, Beyler SA, Lessey BA 2000 Blockade of the α(v)β(3) integrin adversely affects implantation in the mouse. Biol Reprod 62:1285-1290
48. Murray MJ, Lessey BA 1999 Embryo implantation and tumor metastasis: common pathways of invasion and angiogenesis. Semin Reprod Endocrinol 17:275-290
49. Wang L, Zoppe M, Hackeng TM, Griffin JH, Lee KF, Verma IM 1997 A factor IX-deficient mouse model for hemophilia B gene therapy. Proc Natl Acad Sci USA 94:11563-11566